Compass Therapeutics (CMPX) Prepaid Assets (2019 - 2026)
Compass Therapeutics (CMPX) reported Prepaid Assets of $1.0 million for Q1 2026, down 91.31% on a YoY basis from $11.5 million in Q1 2025, and up 9.53% sequentially from $913000.0 in Q4 2025.
Compass Therapeutics (CMPX) Prepaid Assets (2019 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 8 years of Prepaid Assets data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 91.31% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (down 91.31% YoY), and the FY2025 full-year result was $913000.0, down 84.86% from the prior year.
- Prepaid Assets improved to $1.0 million in Q1 2026, from $913000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $11.5 million in Q1 2025 to a low of $913000.0 in Q4 2025.
- A 5-year average of $4.5 million and a median of $3.9 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 388.54% in 2025 and slumped 91.31% in 2026, its largest moves.
- Tracing CMPX's Prepaid Assets over 5 years: stood at $8.2 million in 2022, then slumped by 82.64% to $1.4 million in 2023, then soared by 324.58% to $6.0 million in 2024, then tumbled by 84.86% to $913000.0 in 2025, then gained by 9.53% to $1.0 million in 2026.
- Business Quant data shows CMPX's Prepaid Assets at $1.0 million in Q1 2026, $913000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Compass Therapeutics | 388.64 Mn | 193.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 913,000.00 |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 5.25 Mn |
| Mar 31, 2025 | 11.51 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 6.52 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Mar 31, 2021 | 1.95 Mn |